Idenix Pharmaceuticals to Present at the Third Annual JMP Securities Healthcare Focus Conference.
The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com/. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replays will be available on the Idenix website for weeks following the conference.
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com/.
Idenix Pharmaceuticals Contacts: Amy Sullivan 617-995-9838 (investors) Teri Dahlman 617-995-9905 (media)
CONTACT: Amy Sullivan, investors, +1-617-995-9838, or Teri Dahlman, media, +1-617-995-9905, both of Idenix Pharmaceuticals, Inc.
Web site: http://www.idenix.com/
|Printer friendly Cite/link Email Feedback|
|Date:||Sep 29, 2008|
|Previous Article:||Vanguard Capital Offers Triple Protection for Customer Accounts.|
|Next Article:||AFC Enterprises to Participate in Panel Discussion at RBC Capital Markets 2008 Consumer Conference.|